Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Mar-Apr;26(2):141-7.
doi: 10.2500/ajra.2012.26.3710.

Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis

Peta-Lee Sacks 4th  1 , Richard J Harvey, Janet Rimmer, Richard M Gallagher, Raymond Sacks
Affiliations
Meta-Analysis

Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis

Peta-Lee Sacks 4th et al. Am J Rhinol Allergy. 2012 Mar-Apr.

Abstract

Background: Chronic rhinosinusitis (CRS) is an inflammatory disorder of the nose and sinuses. Because fungi were postulated as a potential cause of CRS in the late 1990s, contrasting articles have advocated and refuted the use of antifungal agents in its management. Although good research shows an interaction of the immune system with fungus in CRS, e.g., allergic fungal sinusitis (AFS), this does not imply that fungi are the cause of CRS or that antifungals will be effective in management. This study was designed to assess the potential advantage of either topical or systemic antifungal therapy in the symptomatic treatment of CRS to aid physicians in making informed decisions about treating patients with CRS.

Methods: A systematic review of the literature was performed with meta-analysis. All studies obtained from searches were reviewed and trials meeting the eligibility criteria were selected. CRS was defined using either the European Position Paper on Rhinosinusitis and Nasal Polyps or American Academy of Otolaryngology-Head and Neck Surgery criteria. Authors were contacted and original data were used for data analysis.

Results: Five studies investigating topical antifungals and one investigating systemic antifungals met the inclusion criteria. All trials were double blinded and randomized. Pooled meta-analysis showed no statistically significant benefit of topical or systemic antifungals over placebo. Symptoms scores statistically favored the placebo group for this outcome. Adverse event reporting was higher in the antifungal group.

Conclusion: Reported side-effects of antifungal therapies may outweigh any potential benefits of treatment based on this meta-analysis and the authors therefore do not advocate the use antifungal treatment in the management of CRS.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart illustrating study selection process.
Figure 2.
Figure 2.
Forest plot illustrating standardized mean differences for symptom scores.
Figure 3.
Figure 3.
Forest plot illustrating standardized mean differences for disease-specific quality-of-life scores.
Figure 4.
Figure 4.
Forest plot illustrating standardized mean differences for nasal endoscopy scores.
Figure 5.
Figure 5.
Forest plot illustrating standardized mean differences for computed tomography scores.
See this image and copyright information in PMC

References

    1. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1–136, 2007. - PubMed
    1. Hutcheson PS, Schubert MS, Slavin RG. Distinctions between allergic fungal rhinosinusitis and chronic rhinosinusitis. Am J Rhinol Allergy 24:405–408. - PubMed
    1. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74:877–884, 1999. - PubMed
    1. Lackner A, Stammberger H, Buzina W, et al. Fungi: A normal content of human nasal mucus. Am J Rhinol 19:125–129, 2005. - PubMed
    1. Ebbens FA, Georgalas C, Rinia AB, et al. The fungal debate: Where do we stand today? Rhinology 45:178–189, 2007. - PubMed